Anzeige
Mehr »
Login
Dienstag, 12.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Die KI-Revolution ist der Super-Megatrend, der Anleger reich machen kann
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W15D | ISIN: US00182C1036 | Ticker-Symbol: BSFA
Tradegate
11.11.24
16:27 Uhr
57,00 Euro
-1,00
-1,72 %
1-Jahres-Chart
ANI PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ANI PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
57,5058,5011.11.
57,5058,0011.11.

Aktuelle News zur ANI PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2024 Earnings Call Transcript3
FrROUNDUP: ANI Pharma Boosts FY24 Outlook As Q3 Results Top Estimates247 WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Friday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) raised its adjusted earnings and net revenue...
► Artikel lesen
FrANI PHARMACEUTICALS INC - 10-Q, Quarterly Report2
ANI PHARMACEUTICALS Aktie jetzt für 0€ handeln
FrANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance77Generated record quarterly net revenues of $148.3 million, representing year-over-year growth of 12.5%, and record Purified Cortrophin® Gel net revenues of $52.6 million, an increase of 76.8% year-over-yearNet...
► Artikel lesen
FrANI PHARMACEUTICALS INC - 8-K, Current Report1
DoA Peek at ANI Pharmaceuticals' Future Earnings1
30.10.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET3
25.10.ANI Pharmaceuticals launches estradiol gel after final FDA approval1
25.10.ANI Pharmaceuticals bringt generisches Estradiol-Gel auf den Markt1
25.10.ANI Pharmaceuticals introduces generic Estradiol Gel1
25.10.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%421PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration...
► Artikel lesen
24.10.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 20242
16.10.Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells 250 Shares of Stock3
11.10.ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential2
11.10.Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights2
26.09.ANI Pharmaceuticals bringt generisches Ketoconazol-Shampoo auf den Markt1
26.09.ANI Pharmaceuticals launches generic Ketoconazole Shampoo3
26.09.ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%130PRINCETON, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration...
► Artikel lesen
20.09.ANI Pharmaceuticals completes acquisition of Alimera Sciences1
17.09.In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals1
Seite:  Weiter >>
83 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1